Robin Wright's most recent trade in Barinthus Biotherapeutics Plc. - ADR was a trade of 48,256 Ordinary Shares done . Disclosure was reported to the exchange on Sept. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 48,256 | 0 | - | - | Ordinary Shares | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 34,328 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 20,394 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 20,174 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,516 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,197 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 18,604 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 20,174 | 20,174 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 19,516 | 19,516 | - | - | Share Option (Right to Buy) |